{"entity":{"id":"nct06966453","kind":"trial","name":"A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer","aka":[],"tldr":"A phase 1/2 trial of Disitamab vedotin in advanced solid tumours, run by Pfizer, active and no longer recruiting.","summary":"A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer is a phase 1/2 interventional study registered as NCT06966453 by Pfizer, with 74 participants enrolled, started 2025-06-30 and due to reach its primary completion in 2027-10-25. Interventions recorded: Disitamab vedotin.","status":"active","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06966453","url":"https://clinicaltrials.gov/study/NCT06966453"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":["adc"],"targets":[],"drugs":["disitamab-vedotin"],"companies":["pfizer"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06966453","phase":"1/2","setting":"A PHASE 1B/2, OPEN-LABEL, MULTICOHORT STUDY OF DISITAMAB VEDOTIN IN ADULTS WITH HER2 EXPRESSING ADVANCED BREAST CANCER","sponsor":"Pfizer","participation":[{"nct":"NCT06966453","source":"https://clinicaltrials.gov/study/NCT06966453","fetchedAt":"2026-10-07T16:55:19.231Z","studySha256":"9ca42984bb5610f7e52136de7a77e1c8491eb5de97e0af9b00a9c4bd5e7e4514","overallStatus":"ACTIVE_NOT_RECRUITING","lastUpdatePosted":"2026-09-09","leadSponsor":"Pfizer","collaboratorCount":0,"minimumAge":"18 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":74,"enrolmentType":"ACTUAL","siteCount":167,"recruitingSiteCount":0,"countries":["Australia","Brazil","Canada","Germany","Italy","Japan","Puerto Rico","Spain","United States"]}],"started":"2025-06-30","startedType":"actual","enrolled":74,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06966453/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"technology":[{"id":"adc","kind":"technology","name":"Antibody-drug conjugate (ADC)","route":"/technologies/adc/"}],"drug":[{"id":"disitamab-vedotin","kind":"drug","name":"Disitamab vedotin","route":"/drugs/disitamab-vedotin/"}],"company":[{"id":"pfizer","kind":"company","name":"Pfizer (incl. Seagen)","route":"/companies/pfizer/"}]}}